智立医学 (430145.OC)

+ 收藏

现金流量表(智立医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 29,075,361.2642,707,477.8521,539,338.0749,379,530.7523,509,946.67
 收到的税费返还(元) 2,128.3321,809.683,894.26216,492.90210,978.75
 收到其他与经营活动有关的现金(元) 200,653.881,880,467.94419,069.01632,769.71146,067.78
 经营活动现金流入小计(元) 29,278,143.4744,609,755.4721,962,301.3450,228,793.3623,866,993.20
 购买商品、接受劳务支付的现金(元) 13,820,883.3836,912,086.2616,443,344.1140,189,364.8618,839,435.79
 支付给职工以及为职工支付的现金(元) 3,395,645.528,163,178.094,909,597.958,465,638.394,781,780.38
 支付的各项税费(元) 555,675.113,136,641.922,232,940.62614,224.36185,870.70
 支付其他与经营活动有关的现金(元) 2,245,312.755,578,700.773,159,299.253,920,987.712,515,704.65
 经营活动现金流出小计(元) 20,017,516.7653,790,607.0426,745,181.9353,190,215.3226,322,791.52
 经营活动产生的现金流量净额(元) 9,260,626.71-9,180,851.57-4,782,880.59-2,961,421.96-2,455,798.32
二、投资活动产生的现金流量
 收回投资收到的现金(元) -20,046,531.5610,046,531.5637,000,000.008,300,000.00
 取得投资收益收到的现金(元) -252,936.76146,522.03900,010.23-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---950,000.00950,000.00
 投资活动现金流入小计(元) -20,299,468.3210,193,053.5938,850,010.239,250,000.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 253,229.451,422,833.021,530,467.863,341,697.522,197,623.52
 投资支付的现金(元) 15,295,434.1421,750,000.0021,050,000.004,550,000.003,500,000.00
 支付其他与投资活动有关的现金(元) -212,884.45---
 投资活动现金流出小计(元) 15,548,663.5923,385,717.4722,580,467.867,891,697.525,697,623.52
 投资活动产生的现金流量净额(元) -15,548,663.59-3,086,249.15-12,387,414.2730,958,312.713,552,376.48
三、筹资活动产生的现金流量
 收到其他与筹资活动有关的现金(元) -1,400,000.00---
 筹资活动现金流入小计(元) -1,400,000.00---
 支付其他与筹资活动有关的现金(元) 339,042.222,498,704.68633,451.96990,770.651,286,229.79
 筹资活动现金流出小计(元) 339,042.222,498,704.68633,451.96990,770.651,286,229.79
 筹资活动产生的现金流量净额(元) -339,042.22-1,098,704.68-633,451.96-990,770.65-1,286,229.79
四、汇率变动对现金及现金等价物的影响(元) 2,291.926,199.8013,688.7931,570.3617,923.70
五、现金及现金等价物净增加额(元) -6,624,787.18-13,359,605.60-17,790,058.0327,037,690.46-171,727.93
 加:期初现金及现金等价物余额(元) 19,836,596.1333,196,201.7333,196,201.736,158,511.276,158,511.27
 期末现金及现金等价物余额(元) 13,211,808.9519,836,596.1315,406,143.7033,196,201.735,986,783.34
补充资料:
 净利润(元) -3,262,157.54-2,419,636.51-5,621,134.47-5,100,205.48-4,494,417.90
 固定资产和投资性房地产折旧(元) 237,502.731,609,859.302,277,013.231,114,360.672,000,197.23
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 237,502.731,609,859.302,277,013.231,114,360.672,000,197.23
 无形资产摊销(元) 79,844.14388,149.99204,671.40392,468.94196,068.54
 长期待摊费用摊销(元) 55,653.521,603,984.95463,746.12106,400.2670,913.01
 递延收益摊销(元) -3,905,000.00---
 处置固定资产、无形资产和其他长期资产的损失(元) --1,764,090.03--296,699.61-325,554.88
 公允价值变动损失(元) ---46,531.56--460,024.29
 财务费用(元) 13,112.58427,578.27212,537.41457,066.06231,694.24
 投资损失(元) 2,203,726.41-957,873.55395,536.2153,025.75414,827.34
 递延所得税(元) 319,491.77393,859.88-721,277.57-54,730.6816,485.82
  其中:递延所得税资产减少(元) 409,655.69-167,334.80-707,419.34-54,537.5316,582.39
 递延所得税负债增加(元) -90,163.92561,194.68-13,858.23-193.15-96.57
 存货的减少(元) 1,844,284.761,300,122.394,344,186.48-817,253.78-2,299,036.49
 经营性应收项目的减少(元) 6,798,974.02-8,163,522.52-3,524,198.86-2,616,501.441,644,419.69
 经营性应付项目的增加(元) 637,630.37-6,188,767.56-1,215,713.46859,570.77575,772.44
 其他(元) --1,615,950.00-1,615,950.00--
 现金的期末余额(元) 13,211,808.9519,836,596.1315,406,143.7033,196,201.735,986,783.34
 减:现金的期初余额(元) 19,836,596.1333,196,201.7333,196,201.736,158,511.276,158,511.27
 现金及现金等价物的净增加额(元) -6,624,787.18-13,359,605.60-17,790,058.0327,037,690.46-171,727.93
公告日期 2024-08-232024-04-292023-08-222023-04-202022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院